. Variant-selective stereopure oligonucleotides protect against pathologies associated with C9orf72-repeat expansion in preclinical models. Nat Commun. 2021 Feb 8;12(1):847. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. FTD Fluid Markers for Degeneration: Check. For Pathology: Not Yet.

Therapeutics

  1. WVE-004

Mutations